INTRODUCTION: We have shown that diesel exhaust (DE) inhalation caused progression of atherosclerosis; however, the mechanisms are not fully understood. We hypothesize that exposure to DE upregulates cyclooxygenase (COX) expression and activity, which could play a role in DE-induced atherosclerosis. METHODS: ApoE knockout mice (30-week old) fed with regular chow were exposed to DE (at 200 µg/m(3) of particulate matter) or filtered air (control) for 7 weeks (6 h/day, 5 days/week). The protein and mRNA expression of COX-1 and COX-2 were evaluated by immunohistochemistry analysis and quantitative real-time PCR, respectively. To examine COX activity, thoracic aortae were mounted in a wire myograph, and phenylephrine (PE)-stimulated vasoconstriction was measured with and without the presence of COX antagonists (indomethacin). COX-2 activity was further assessed by urine 2,3-dinor-6-keto PGF(1α) level, a major metabolite of prostacyclin I(2) (PGI(2)). RESULTS: Immunohistochemistry analysis demonstrates that DE exposure enhanced COX-2 expression in both thoracic aorta (p < 0.01) and aortic root (p < 0.03), with no modification of COX-1 expression. The increased COX-2 expression was positively correlated with smooth muscle cell content in aortic lesions (R(2) = 0.4081, p < 0.008). The fractional changes of maximal vasoconstriction in the presence of indomethacin was attenuated by 3-fold after DE exposure (p < 0.02). Urine 2,3-dinor-6-keto PGF(1α) level was 15-fold higher in DE group than the control (p < 0.007). The mRNA expression of COX-2 (p < 0.006) and PGI synthase (p < 0.02), but not COX-1, was significantly augmented after DE exposure. CONCLUSION: We show that DE inhalation enhanced COX-2 expression, which is also associated with phenotypic changes of aortic lesion.
INTRODUCTION: We have shown that diesel exhaust (DE) inhalation caused progression of atherosclerosis; however, the mechanisms are not fully understood. We hypothesize that exposure to DE upregulates cyclooxygenase (COX) expression and activity, which could play a role in DE-induced atherosclerosis. METHODS:ApoE knockout mice (30-week old) fed with regular chow were exposed to DE (at 200 µg/m(3) of particulate matter) or filtered air (control) for 7 weeks (6 h/day, 5 days/week). The protein and mRNA expression of COX-1 and COX-2 were evaluated by immunohistochemistry analysis and quantitative real-time PCR, respectively. To examine COX activity, thoracic aortae were mounted in a wire myograph, and phenylephrine (PE)-stimulated vasoconstriction was measured with and without the presence of COX antagonists (indomethacin). COX-2 activity was further assessed by urine 2,3-dinor-6-keto PGF(1α) level, a major metabolite of prostacyclin I(2) (PGI(2)). RESULTS: Immunohistochemistry analysis demonstrates that DE exposure enhanced COX-2 expression in both thoracic aorta (p < 0.01) and aortic root (p < 0.03), with no modification of COX-1 expression. The increased COX-2 expression was positively correlated with smooth muscle cell content in aortic lesions (R(2) = 0.4081, p < 0.008). The fractional changes of maximal vasoconstriction in the presence of indomethacin was attenuated by 3-fold after DE exposure (p < 0.02). Urine 2,3-dinor-6-keto PGF(1α) level was 15-fold higher in DE group than the control (p < 0.007). The mRNA expression of COX-2 (p < 0.006) and PGI synthase (p < 0.02), but not COX-1, was significantly augmented after DE exposure. CONCLUSION: We show that DE inhalation enhanced COX-2 expression, which is also associated with phenotypic changes of aortic lesion.
Authors: Michael E Burleigh; Vladimir R Babaev; Patricia G Yancey; Amy S Major; Jennifer L McCaleb; John A Oates; Jason D Morrow; Sergio Fazio; Macrae F Linton Journal: J Mol Cell Cardiol Date: 2005-09 Impact factor: 5.000
Authors: Christoph Franz Adam Vogel; Eric Sciullo; Pat Wong; Paul Kuzmicky; Norman Kado; Fumio Matsumura Journal: Environ Health Perspect Date: 2005-11 Impact factor: 9.031
Authors: Zhonghai Yan; Hanjie Zhang; Christina Maher; Emilio Arteaga-Solis; Frances A Champagne; Licheng Wu; Jacob D McDonald; Beizhan Yan; Gary J Schwartz; Rachel L Miller Journal: PLoS One Date: 2014-10-27 Impact factor: 3.240
Authors: Jian Zhu; Yaming Zhao; Yizhen Gao; Chunyan Li; Liting Zhou; Wen Qi; Yuezhu Zhang; Lin Ye Journal: Int J Environ Res Public Health Date: 2019-04-19 Impact factor: 3.390
Authors: Giuseppe Lo Sasso; Walter K Schlage; Stéphanie Boué; Emilija Veljkovic; Manuel C Peitsch; Julia Hoeng Journal: J Transl Med Date: 2016-05-20 Impact factor: 5.531